| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.045 | 0.4 |